Want to join the conversation?
Products and services distributor company $DXPE posted lower earnings during 2Q16 due to sequential improvement on GM and reductions within SG&A expenses. Net income was $5.14MM or $0.34 per diluted share vs. $7.14MM or $0.47 per diluted share in 2Q15. Sales fell 20.8% to 256.2MM vs. 2Q15, hurt by lower sales results in its segments.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?